1. Protein Tyrosine Kinase/RTK
  2. VEGFR
  3. Peptide HRH acetate

Peptide HRH acetate is a polypeptide that specifically binds to VEGF receptors. Peptide HRH acetate inhibits VEGF-stimulated endothelial cell proliferation. Peptide HRH acetate inhibits angiogenesis and suppresses corneal neovascularization. Peptide HRH acetate can be used in anti-angiogenesis related studies.

For research use only. We do not sell to patients.

Custom Peptide Synthesis

Peptide HRH acetate

Peptide HRH acetate Chemical Structure

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Peptide HRH acetate:

Top Publications Citing Use of Products

View All VEGFR Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Peptide HRH acetate is a polypeptide that specifically binds to VEGF receptors. Peptide HRH acetate inhibits VEGF-stimulated endothelial cell proliferation. Peptide HRH acetate inhibits angiogenesis and suppresses corneal neovascularization. Peptide HRH acetate can be used in anti-angiogenesis related studies[1].

In Vitro

Peptide HRH (0.95-3.85 μg/μL; 96 h) acetate dose-dependently inhibits the proliferation of VEGF-stimulated human umbilical vein endothelial cells (HUVECs)[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: human umbilical vein endothelial cells (HUVECs) stimulated with VEGF
Concentration: 0.95; 1.9; 3.85 μg/μL
Incubation Time: 96 h
Result: Suppressed the proliferation of VEGF-stimulated HUVECs in a dose-dependent manner.
In Vivo

Peptide HRH (10-50 μg/μL; local application to CAM; 48 h) acetate dose-dependently suppresses angiogenesis in the chick CAM model[1].
Peptide HRH (10 μg/μL; topical eye drops; four times per day; 14 days) acetate significantly inhibits corneal neovascularization in the alkali-burned rat corneal model[1].
Peptide HRH (10 μg/μL; topical eye drops; four times per day; 14 days) acetate significantly inhibits corneal neovascularization in the suture-induced rat corneal model[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Sprague-Dawley (male, alkali-burned corneal model)[1]
Dosage: 10 μg/μL
Administration: topical eye drops; four times per day; 14 days
Result: Significantly reduced corneal neovascularization area from days 3 to 14 post-burn.
Kept most of the corneal stroma free of blood vessels.
Animal Model: Sprague-Dawley (male, suture-induced corneal model)[1]
Dosage: 10 μg/μL
Administration: topical eye drops; four times per day; 14 days
Result: Significantly reduced maximum vessel length and total corneal neovascularization area from days 3 to 14 post-suture.
Molecular Weight

1521.69 (free base)

Formula

C64H104N28O16·xC2H4O2

Appearance

Solid

Color

White to off-white

Sequence

His-Arg-His-Thr-Lys-Gln-Arg-His-Thr-Ala-Leu-His

Sequence Shortening

HRHTKQRHTALH

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Sealed storage, away from moisture

Powder -80°C 2 years
-20°C 1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvent & Solubility
In Vitro: 

H2O : 100 mg/mL (Need ultrasonic)

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Peptide HRH acetate
Cat. No.:
HY-P11775A
Quantity:
MCE Japan Authorized Agent: